The Senescence-Associated Secretory Phenotype: Critical Effector in Skin Cancer and Aging
1Epigenetics Program, Department of Cell and Developmental Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Abstract:
Cellular senescence, a state of stable cell cycle arrest in response to cellular stress, is an indispensable mechanism to counter tumorigenesis by halting the proliferation of damaged cells. However, through the secretion of an array of diverse cytokines, chemokines, growth factors, and proteases known as the senescence-associated secretory phenotype (SASP), senescent cells can paradoxically promote carcinogenesis. Consistent with this, removal of senescent cells delays the onset of cancer and prolongs lifespan in vivo, potentially in part through SASP reduction. In this review, we consider the evidence for the SASP and "SASP-like" inflammation in driving skin carcinogenesis, emphasizing how further understanding of both the roles and mechanisms of SASP expression may offer new targets for skin cancer prevention and therapy.
Insights
Cellular senescence halts damaged cell growth but its associated secretory phenotype (SASP) can paradoxically promote skin cancer. Targeting SASP may offer new prevention and therapy strategies.
Area of Science:
- Oncology
- Cell Biology
- Dermatology
Background:
- Cellular senescence is a key anti-cancer mechanism that arrests proliferation of damaged cells.
- Senescent cells secrete factors (SASP) that can paradoxically promote cancer.
- Removing senescent cells and reducing SASP may delay cancer onset and extend lifespan.
Purpose of the Study:
- To review the evidence linking SASP and inflammation to skin carcinogenesis.
- To highlight SASP mechanisms as potential targets for skin cancer prevention and therapy.
Main Methods:
- Literature review of studies on cellular senescence, SASP, and skin cancer.
- Analysis of the dual role of SASP in tumor suppression and promotion.
- Examination of SASP-like inflammation in skin carcinogenesis.
Main Results:
- Senescence is a double-edged sword in cancer, initially protective but potentially promoting it via SASP.
- SASP and SASP-like inflammation are implicated in driving skin carcinogenesis.
- Evidence suggests SASP reduction could be a therapeutic strategy.
Conclusions:
- Understanding SASP's role in skin cancer is crucial for developing novel therapeutic strategies.
- Targeting SASP and related inflammation presents a promising avenue for skin cancer prevention and treatment.
Related Concept Videos
Renewal of Skin Epidermal Stem Cells
The Effect of Aging on Tissues
Replicative Cell Senescence
Replicative Cell Senescence
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Clinical Applications of Epidermal Stem Cells


